Better Therapeutics Inc. (BTTX): Is this the Most Sought-After Stock Today?

view original post

Let’s start up with the current stock price of Better Therapeutics Inc. (BTTX), which is $1.21 to be very precise. The Stock rose vividly during the last session to $0.969 after opening rate of $0.9362 while the lowest price it went was recorded $0.912 before closing at $0.91.Recently in News on April 6, 2022, Better Therapeutics Announces Key Milestones and Updates for Ongoing Studies of its Digital Therapeutics Approach for Cardiometabolic Diseases. First Study of Nutritional Cognitive Behavioral Therapy for Fatty Liver Disease and Expanded Real-World Evidence Studies for Type 2 Diabetes Follow Promising Primary Endpoint Clinical Trial Data. You can read further details here

Better Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.1300 on 01/06/22, with the lowest value was $0.9120 for the same time period, recorded on 04/29/22.

Better Therapeutics Inc. (BTTX) full year performance was -90.88%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Better Therapeutics Inc. shares are logging -95.90% during the 52-week period from high price, and 32.31% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.91 and $29.40.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 27734311 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Better Therapeutics Inc. (BTTX) recorded performance in the market was -80.39%, having the revenues showcasing -74.74% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 22.70M, as it employees total of 44 workers.

The Analysts eye on Better Therapeutics Inc. (BTTX)

During the last month, 0 analysts gave the Better Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 3.3317, with a change in the price was noted -5.64. In a similar fashion, Better Therapeutics Inc. posted a movement of -82.58% for the period of last 100 days, recording 438,833 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BTTX is recording 0.26 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.26.

Technical rundown of Better Therapeutics Inc. (BTTX)

Raw Stochastic average of Better Therapeutics Inc. in the period of last 50 days is set at 6.64%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 21.58%. In the last 20 days, the company’s Stochastic %K was 7.69% and its Stochastic %D was recorded 3.32%.

Considering, the past performance of Better Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -80.39%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -91.26%, alongside a downfall of -90.88% for the period of the last 12 months. The shares increased approximately by -27.04% in the 7-day charts and went up by -55.73% in the period of the last 30 days. Common stock shares were lifted by -74.74% during last recorded quarter.